Beyond Outcomes - Clinical Research Unfiltered

Beyond Outcomes - Clinical Research Unfiltered is a podcast exploring the real stories, challenges, and decisions behind clinical research, medical innovation, and healthcare transformation.

Hosted through open conversations with experts, founders, researchers, and industry leaders, the podcast goes beyond polished success stories to uncover what it really takes to bring ideas, trials, technologies, and treatments closer to patients.

From regulatory hurdles and clinical operations to entrepreneurship, digital health, patient impact, and lessons learned along the way, Beyond Outcomes offers an honest look at the people and processes shaping the future of healthcare.

Beyond Outcomes - Clinical Research Unfiltered

Neueste Episoden

From CRO Founder to Business Angel: Rethinking Clinical Research and Leadership

From CRO Founder to Business Angel: Rethinking Clinical Research and Leadership

‧ 85m 39s

What does it take to build a clinical research company—and how do you know when it is time to let someone else lead it?
In this episode of Beyond Outcomes – Clinical Research Unfiltered, Andreas Beust speaks with Andreas Grund, founder of GCP-Service and business angel, about his journey from academic research to CRO entrepreneurship, international collaboration, and investing in medical-device startups.
Andreas shares how GCP-Service grew from a one-person operation into an international business, why adapting to clients’ needs shaped his approach, and what he learned about trust, responsibility, and managing a growing team through uncertain times. He reflects...

From Wellness App to Digital Health Application: Building a Digital Therapeutic in Europe

From Wellness App to Digital Health Application: Building a Digital Therapeutic in Europe

‧ 106m 57s

What does it really take to turn a digital health idea into a regulated, reimbursed medical product?

In this episode of Beyond Outcomes - Clinical Research Unfiltered, Andreas Beust speaks with Lenka Šomvárska, Co-Founder of Vitadio, about the long and often unpredictable journey from a wellness startup to a digital therapeutic for people with type 2 diabetes.

Lenka shares how Vitadio pivoted from wellness and obesity into diabetes, why the team deliberately chose the more demanding path of becoming a regulated medical device, and what they learned while generating clinical evidence, obtaining CE marking, navigating the transition from MDD to...

From Pathology to Biotech: Unlocking Impact Beyond Patient Care

From Pathology to Biotech: Unlocking Impact Beyond Patient Care

‧ 52m 42s

What happens when the career you once imagined for yourself no longer feels like the right one?

In this episode of Beyond Outcomes – Clinical Research Unfiltered, Michelle Mudge-Riley shares her journey from medicine and pathology to entrepreneurship, consulting, and ultimately leadership in biotech. What began as a difficult decision to step away from the traditional physician career evolved into a new way of creating impact for patients—through clinical development.

The conversation moves from career transformation into the realities of biotech: balancing strong science with business strategy, choosing development pathways, interpreting clinical data, working across regulatory environments, and understanding what...

Who Decides What Evidence Is Enough? The Reality of Medical Device Regulation

Who Decides What Evidence Is Enough? The Reality of Medical Device Regulation

‧ 139m 13s

European medical device regulation is designed to protect patients—but does the current system provide innovators with enough clarity to develop the technologies patients need?

In this episode of Beyond Outcomes: Clinical Research Unfiltered, Andreas Beust speaks with Prof. Tom Melvin, whose career spans medicine, law, regulatory authorities, European policy, and academic research.

Together, they unpack the complex architecture of the European medical device system: the responsibilities of competent authorities and notified bodies, the growing influence of MDCG guidance and ISO standards, and the continuing uncertainty surrounding clinical evidence requirements.

The conversation also explores early regulatory advice, structured dialogue, randomized trials,...